Medscape InDiscussion: Endometrial Cancer
von Medscape
What Can Risk Factors Teach Us About Endometrial Cancer?
Über diesen Podcast
Listen to Medscape InDiscussion: Endometrial Cancer, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-endometrial-cancer-s1-ep1-2026a10007qe. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Folgen
- What Can Risk Factors Teach Us About Endometrial Cancer? · 25 Min. · Staffel 3 Folge 6Drs Ursula A. Matulonis and Immaculata De Vivo discuss the epidemiology of endometrial cancer and how clinicians can use information about risk factors. Relevant disclosures can…
- The Future of Endometrial Cancer Pathology · 27 Min. · Staffel 3 Folge 5Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role in the diagnosis of endometrial cancer. Relevant…
- From Carcinosarcoma to Circulating Tumor DNA: The Importance of Investigator-Initiated Research in Endometrial Cancer · 24 Min. · Staffel 3 Folge 4Drs Ursula A. Matulonis and Stephanie Lheureux discuss the importance of investigator-initiated clinical trials in endometrial cancer, research on carcinosarcoma, and ctDNA…
- Endometrial Cancer: SWI/SNF Complexes, GLP-1 Receptor Agonists, and the Future of Research and Treatment · 22 Min. · Staffel 3 Folge 3Drs Ursula Matulonis and Jessica St. Laurent discuss endometrial cancer research, funding, early detection, and treatment, including the impact of GLP-1 receptor agonists…
- Route 66 SPORE and the Direction of Endometrial Cancer Research · 23 Min. · Staffel 3 Folge 2Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE. Relevant disclosures can be found with the episode…
- The Future of Endometrial Cancer Therapeutics: Phase 3 Trials of ADCs and Beyond · 25 Min. · Staffel 3 Folge 1Drs Ursula Matulonis and Brian Slomovitz discuss phase 3 trials of ADCs in endometrial cancer and what's to come in the field of endometrial cancer therapeutics. Relevant…
- Can the Use of ADCs in Breast Cancer Teach Us About Resistance Mechanisms and Sequencing in Endometrial Cancer? · 26 Min. · Staffel 2 Folge 6Drs Ursula A. Matulonis and Leif W. Ellisen discuss endometrial cancer and ADCs, including resistance mechanisms, ADC sequencing, what's exciting in the field, and novel…
- The Future of Replication Stress and DNA Damage and Repair in Endometrial Cancer · 26 Min. · Staffel 2 Folge 5Drs Ursula A. Matulonis and Joyce F. Liu discuss targeting DNA damage and repair and replication stress in endometrial cancer. Relevant disclosures can be found with the episode…
- Endometrial Cancer Trends: Immunotherapy Insights and Research Priorities · 23 Min. · Staffel 2 Folge 4Drs Ursula A. Matulonis and Gini Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field. Relevant disclosures can…
- Endometrial Cancer: Molecular Classification, Genetics, When to Rebiopsy, and What's New in the Research · 26 Min. · Staffel 2 Folge 3Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to…
- Endometrial Cancer Disparities: Improving Black Women's Access to Care and Trials · 27 Min. · Staffel 2 Folge 2Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women. Relevant…
- Metastatic Endometrial Cancer: Hormonal Therapy Updates and Ways to Target and Treat ER+ Disease · 29 Min. · Staffel 2 Folge 1Drs Ursula A. Matulonis and Panagiotis A. Konstantinopoulos discuss hormonal therapy updates and different ways to target and treat ER+ metastatic endometrial cancer. Relevant…
- Radiation Oncology and Its Role in the Treatment of Endometrial Cancer · 23 Min. · Staffel 1 Folge 6Drs Ursula A. Matulonis and Akila N. Viswanathan discuss the role of radiation therapy in endometrial cancer, including staging, immunotherapy, and treatment disparities…
- Immunotherapy, Novel Therapies, and Shared Decision-Making in Advanced Endometrial Cancer · 25 Min. · Staffel 1 Folge 5Drs Ursula A. Matulonis and Mansoor Mirza discuss immunotherapy trials, novel therapies such as CDK4/6 inhibitors and antibody-drug conjugates, and shared decision-making…
- What Can We Do About Health Disparities in the Diagnosis and Treatment of Endometrial Cancer? · 24 Min. · Staffel 1 Folge 4Drs Ursula A. Matulonis and Bhavana Pothuri discuss solutions to address health disparities in the diagnosis and treatment of endometrial cancer. Relevant disclosures can be…
- What Do We Need to Know About New Therapeutics for Patients With Endometrial Cancer? · 26 Min. · Staffel 1 Folge 3Drs Ursula A. Matulonis and Joyce F. Liu discuss new therapeutics for patients with endometrial cancer, including ADCs, immunotherapy, and drugs targeting replication stress…
- How Can Oncologists Address Endometrial Cancer Survivorship Needs to Improve Patient Quality of Life? · 25 Min. · Staffel 1 Folge 2Drs Ursula A. Matulonis and Alexi A. Wright discuss survivorship issues in endometrial cancer including sexual dysfunction, mental health, fatigue, and peripheral neuropathy…
- Antibody-Drug Conjugates and Endometrial Cancer: Combinations, Response Rates, and Clinical Trials · 28 Min. · Staffel 1 Folge 1Drs Ursula A. Matulonis and Kathleen N. Moore discuss the different aspects of antibody-drug conjugates (ADCs) in endometrial cancer, medications that are currently available…








